Coagulation Factor Concentrates
A Global Strategic Business Report
MCP17741
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (18431)
460
CXO1539
VICE PRESIDENT7653
DIRECTOR6141
MANAGER2638
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Coagulation Factor Concentrates Market to Reach US$14.2 Billion by 2030
The global market for Coagulation Factor Concentrates estimated at US$9.3 Billion in the year 2024, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.8 Billion by the end of the analysis period. Growth in the Clinical Research Laboratories segment is estimated at 7.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 10.7% CAGR
The Coagulation Factor Concentrates market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 10.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.
Global Coagulation Factor Concentrates Market - Key Trends and Drivers Summarized
What Are Coagulation Factor Concentrates and How Do They Work?
Coagulation factor concentrates are specialized therapeutic products that play a critical role in the management of hemophilia and other bleeding disorders. These concentrates are formulated to replace missing or deficient clotting factors in individuals with coagulation disorders, thereby restoring the normal blood clotting process. The human coagulation cascade involves a complex series of interactions between various clotting factors, such as Factor VIII and Factor IX, which work together to form a stable blood clot at the site of a blood vessel injury. In patients with conditions like hemophilia A and B, these factors are either deficient or dysfunctional, leading to prolonged bleeding episodes that can result in severe complications. Coagulation factor concentrates can be derived from human plasma or manufactured using recombinant DNA technology. Plasma-derived concentrates are extracted and purified from donated blood, while recombinant products are synthetically engineered in laboratory settings, reducing the risk of blood-borne infections. Once administered intravenously, these concentrates quickly elevate the patient’s factor levels to therapeutic concentrations, promoting effective clot formation and reducing bleeding risks. Over time, advancements in production methods have improved the safety, efficacy, and ease of administration of these life-saving products, making them an essential component in modern hemophilia care.
Why Are Coagulation Factor Concentrates Considered a Breakthrough in Treating Hemophilia and Bleeding Disorders?
Coagulation factor concentrates represent a major breakthrough in the treatment of hemophilia and other bleeding disorders due to their ability to prevent and control bleeding episodes with precision and reliability. Before the introduction of factor concentrates, patients relied on whole blood transfusions or plasma infusions, which were less effective and carried a higher risk of viral transmission and immunogenic complications. The advent of factor concentrates has dramatically improved patient outcomes by enabling on-demand and prophylactic (preventive) treatment approaches. On-demand treatment involves administering concentrates at the first sign of bleeding to quickly stop the episode, while prophylactic regimens involve regular infusions to maintain clotting factor levels, thereby preventing spontaneous bleeds and protecting against joint damage, which is a common complication in hemophilia patients. Prophylactic therapy has been shown to significantly enhance the quality of life for patients, allowing them to engage in normal daily activities with reduced fear of bleeding. Additionally, newer generations of coagulation factor concentrates, such as extended half-life (EHL) products, have been developed to stay in the bloodstream longer, reducing the frequency of infusions needed and improving patient compliance. The availability of these products has revolutionized the management of hemophilia, transforming it from a life-threatening condition to a manageable chronic disease.
How Are Emerging Technologies and Research Advancing Coagulation Factor Concentrates?
Recent advancements in biotechnology and pharmaceutical research are pushing the boundaries of what is possible with coagulation factor concentrates, leading to safer, more effective, and longer-lasting treatment options. One major area of innovation is the development of extended half-life (EHL) coagulation factors, which are engineered to remain active in the bloodstream for longer periods. This is achieved through modifications such as PEGylation (attachment of polyethylene glycol molecules) or fusion with the Fc region of immunoglobulins, which delay the body’s natural clearance of the factor. As a result, patients require fewer infusions, reducing the treatment burden and enhancing adherence. Another significant breakthrough is the rise of recombinant products that are produced without the use of animal or human proteins, virtually eliminating the risk of contamination and adverse immune reactions. These products are not only safer but also more consistent in quality and efficacy. Gene therapy is an emerging frontier that promises to reshape the entire landscape of hemophilia treatment. Experimental gene therapies aim to introduce functional copies of the defective genes responsible for hemophilia, potentially providing a one-time, curative solution by enabling the patient’s own cells to produce the missing clotting factors. Early clinical trials have shown promising results, with sustained factor production and reduced bleeding rates in participants. Furthermore, innovative delivery mechanisms such as subcutaneous formulations and non-intravenous routes are under investigation, which could make treatment more accessible and less invasive.
What Factors Are Fueling the Expansion of the Coagulation Factor Concentrates Market?
The growth in the coagulation factor concentrates market is driven by several factors, primarily the increasing prevalence of bleeding disorders, advancements in biotechnological manufacturing, and rising awareness of early diagnosis and prophylactic treatment strategies. One of the main growth drivers is the rising global incidence of hemophilia and other rare bleeding disorders, which necessitates effective and reliable treatment options. As diagnostic capabilities improve, more patients are being accurately diagnosed and treated, expanding the patient pool for coagulation factor concentrates. Another significant driver is the shift towards prophylactic treatment regimens, which require regular use of these concentrates to prevent bleeds rather than treating them reactively. This shift is increasing the overall demand for these products, particularly for newer, extended half-life versions that offer the convenience of less frequent dosing. Additionally, advancements in recombinant technology and gene therapy are driving innovation in the market, with pharmaceutical companies investing heavily in research and development to create safer and more effective products. The introduction of novel products that offer longer-lasting effects, fewer side effects, and improved safety profiles is attracting more patients and clinicians to adopt these newer treatments. Regulatory approvals and supportive government policies are also contributing to market growth, as they facilitate faster access to new therapies. For example, the FDA and EMA have been increasingly approving new factor concentrates, including those with extended half-lives and non-intravenous administration methods. Furthermore, the trend towards home-based care and self-administration is expanding the market, as patients seek greater independence and flexibility in managing their conditions. The rising investments in research aimed at improving the quality and durability of coagulation factor concentrates, combined with the potential for gene therapy to serve as a long-term solution, are expected to continue driving growth in this market, positioning it for sustained expansion in the years to come.
SCOPE OF STUDY
The report analyzes the Coagulation Factor Concentrates market by the following Segments, and Geographic Regions/Countries:
Segments:
End-Use (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..
SELECT PLAYERS
Bayer AG; Bio Products Laboratory Limited; Biotest AG; Coagulation Sciences; CSL Ltd.; FFF Enterprises, Inc.; Gesan Production Srl; Grifols International SA; Guangzhou Wondfo Biotech Co., Ltd; Japan Blood Products Organization
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| Global Economic Update |
| Coagulation Factor Concentrates – Global Key Competitors Percentage Market Share in 2024 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 113 Players Worldwide in 2024 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Prevalence of Hemophilia and Other Bleeding Disorders Throws the Spotlight on Coagulation Factor Concentrates |
| Growing Adoption in Prophylactic Treatment Regimens Propels Market Growth for Coagulation Factor Concentrates |
| Increasing Awareness of Early Diagnosis and Treatment Strengthens the Business Case for Coagulation Factor Therapy |
| Expanding Use in Surgical and Trauma Settings Generates Demand for Coagulation Factor Concentrates in Critical Care |
| Shift Toward Recombinant Factor Concentrates Expands Addressable Market for Safe and Pure Coagulation Solutions |
| Rising Adoption of Long-Acting Factor Concentrates Drives Demand for Improved Patient Compliance |
| Here`s the Story: Growing Preference for Personalized Medicine Sustains Market Growth for Tailored Coagulation Therapies |
| Innovations in Gene Therapy Propel Interest in Next-Generation Coagulation Factor Treatments |
| Rising Use in Treating Rare Bleeding Disorders Creates Niche Growth Opportunities for Specialized Factor Concentrates |
| Growing Demand for Plasma-Derived Products Generates Opportunities for Coagulation Factor Concentrates in Developing Regions |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Coagulation Factor Concentrates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Clinical Research Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Clinical Research Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030 |
| World Coagulation Factor Concentrates Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| JAPAN |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| CHINA |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| EUROPE |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Coagulation Factor Concentrates by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| FRANCE |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| GERMANY |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| SPAIN |
| Spain Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Spain Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Spain 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| RUSSIA |
| Russia Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Russia Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Russia 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Coagulation Factor Concentrates by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| AUSTRALIA |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E) |
| Australia Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Australia Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Australia 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| INDIA |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E) |
| India Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| India Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| India 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| SOUTH KOREA |
| South Korea Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| South Korea Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| South Korea 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Asia-Pacific Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| LATIN AMERICA |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E) |
| Latin America Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Coagulation Factor Concentrates by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030 |
| Latin America Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Latin America Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Latin America 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| ARGENTINA |
| Argentina Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Argentina Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Argentina 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| BRAZIL |
| Brazil Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Brazil Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Brazil 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| MEXICO |
| Mexico Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Mexico Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Mexico 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| REST OF LATIN AMERICA |
| Rest of Latin America Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Latin America Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Latin America 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| MIDDLE EAST |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E) |
| Middle East Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Coagulation Factor Concentrates by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Coagulation Factor Concentrates by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030 |
| Middle East Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Middle East Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Middle East 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| IRAN |
| Iran Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Iran Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Iran 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| ISRAEL |
| Israel Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Israel Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Israel 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| SAUDI ARABIA |
| Saudi Arabia Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Saudi Arabia Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Saudi Arabia 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| UNITED ARAB EMIRATES |
| UAE Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| UAE Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| UAE 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| REST OF MIDDLE EAST |
| Rest of Middle East Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Rest of Middle East Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Rest of Middle East 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
| AFRICA |
| Coagulation Factor Concentrates Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E) |
| Africa Recent Past, Current & Future Analysis for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR |
| Africa Historic Review for Coagulation Factor Concentrates by End-Use - Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR |
| Africa 15-Year Perspective for Coagulation Factor Concentrates by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics, Clinical Research Laboratories and Academic Institutes for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]